Dow Down 0.62% Nasdaq Down 1.14%

Merrimack Pharmaceuticals, Inc. (MACK)

-NasdaqGM
7.17 Down 0.12(1.65%) 4:00PM EDT
Prev Close:7.29
Open:7.27
Bid:6.95 x 300
Ask:7.17 x 1000
1y Target Est:13.67
Beta:1.43
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:7.05 - 7.30
52wk Range:2.05 - 8.25
Volume:865,312
Avg Vol (3m):1,522,640
Market Cap:749.89M
P/E (ttm):N/A
EPS (ttm):-1.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for MACK

Comparison

Symbol% ChgMkt Cap
MACKDown 1.65%749.89M
IMMUDown 2.45%297.03M
LRUSF 0.00%N/A
THLDDown 10.96%236.28M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):13.73
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.99
Quarterly EPS Est (Sep-14) :-0.28
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):-1.31

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback